Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human gut metagenome

ABSTRACT: Disturbance of gut microbiota in chronic kidney disease

PROVIDER: PRJNA687563 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13328200_1.fastq.gz	Fastqsanger.gz
	SRR13328200_2.fastq.gz	Fastqsanger.gz
	SRR13328300_1.fastq.gz	Fastqsanger.gz
	SRR13328300_2.fastq.gz	Fastqsanger.gz
	SRR13328400_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 616

Similar Datasets

Relating human gut metagenome and metaproteome

Project description:Gut microbiome research is rapidly moving towards the functional characterization of the microbiota by means of shotgun meta-omics. Here, we selected a cohort of healthy subjects from an indigenous and monitored Sardinian population to analyze their gut microbiota using both shotgun metagenomics and shotgun metaproteomics. We found a considerable divergence between genetic potential and functional activity of the human healthy gut microbiota, in spite of a quite comparable taxonomic structure revealed by the two approaches. Investigation of inter-individual variability of taxonomic features revealed Bacteroides and Akkermansia as remarkably conserved and variable in abundance within the population, respectively. Firmicutes-driven butyrogenesis (mainly due to Faecalibacterium spp.) was shown to be the functional activity with the higher expression rate and the lower inter-individual variability in the study cohort, highlighting the key importance of the biosynthesis of this microbial by-product for the gut homeostasis. The taxon-specific contribution to functional activities and metabolic tasks was also examined, giving insights into the peculiar role of several gut microbiota members in carbohydrate metabolism (including polysaccharide degradation, glycan transport, glycolysis and short-chain fatty acid production). In conclusion, our results provide useful indications regarding the main functions actively exerted by the gut microbiota members of a healthy human cohort, and support metaproteomics as a valuable approach to investigate the functional role of the gut microbiota in health and disease.

2017-07-19 | PXD005780 | Pride

E-GEOD-48944

Project description:Gene expression profiles of Chronic kidney disease

2025-01-24 | E-GEOD-48944 | ExpressionAtlas

gut metagenome

Project description:gut metagenome for chronic kidney disease

| PRJNA890567 | ENA

gut microbiota in chronic kidney disease

Project description:gut microbiota in chronic kidney disease

| PRJEB5761 | ENA

human gut metagenome

Project description:Altered Gut Microbiome due to Chronic Kidney Disease Increases COVID-19 Mortality

| PRJNA1057967 | ENA

E-GEOD-66494

Project description:Development of gene expression profiles in human chronic kidney disease

2025-01-24 | E-GEOD-66494 | ExpressionAtlas

human gut metagenome

Project description:chronic kidney

| PRJNA1058580 | ENA

Metabolomic interplay between the gut microbiome and plasma in CSA-AKI patients

Project description:Low cardiac output and kidney congestion are related to cardiac surgery-associated acute kidney injury (CSA-AKI), which is one of the most prevalent complications of cardiac surgery. This pathological process may be connected with a great risk of developing chronic kidney disease and mortality. This study aimed to investigate the possible correlations between gut microbiota metabolism and CSA-AKI.

2022-10-11 | PXD037304 |

E-MTAB-8550

Project description:Gut microbiota and gallstone formation - cohousing study

2020-01-10 | E-MTAB-8550 | ExpressionAtlas

Gut-Derived Metabolite Trimethylamine N-Oxide Promotes Inflammation and Fibrosis Following Ischemia/Reperfusion through CCR2-Mediated Macrophage Infiltration

Project description:Inflammation plays a crucial role in the development of acute kidney injury (AKI) and subsequent chronic kidney disease (CKD) following renal ischemia-reperfusion (IR). It has been demonstrated that metabolites from the gut microbiota can trigger inflammatory responses and modulate renal damage induced by IR. However, the exact driving factors and underlying mechanisms of this process remain unclear. Trimethylamine N-oxide (TMAO), a choline metabolite derived from the gut, has been observed to increase in AKI and CKD patients. Our study reveals that glycyrrhizic acid (GA) exacerbates IR-induced AKI and subsequent CKD through TMAO. To delve into the underlying mechanisms, we employed single-cell sequencing to construct a molecular map of kidney cells.

2024-09-09 | GSE244890 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data